Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer L Xiao, A Parolia, Y Qiao, P Bawa, S Eyunni, R Mannan, SE Carson, ... Nature 601 (7893), 434-439, 2022 | 127 | 2022 |
Protein kinase inhibitors T Linnanen, G Wohlfahrt, S Nanduri, R Ujjinamatada, S Rajagopalan, ... US Patent 9,447,091, 2016 | 42 | 2016 |
Discovery of CA-4948, an orally bioavailable IRAK4 inhibitor for treatment of hematologic malignancies VR Gummadi, A Boruah, BR Ainan, BR Vare, S Manda, HP Gondle, ... ACS Medicinal Chemistry Letters 11 (12), 2374-2381, 2020 | 39 | 2020 |
Discovery of pyridyl bis (oxy) dibenzimidamide derivatives as selective matriptase inhibitors R Goswami, S Mukherjee, G Wohlfahrt, C Ghadiyaram, J Nagaraj, ... ACS medicinal chemistry letters 4 (12), 1152-1157, 2013 | 32 | 2013 |
Indazole and azaindazole compounds as irak-4 inhibitors VR Gummadi, S Samajdar, S Mukherjee US Patent App. 15/744,448, 2018 | 28 | 2018 |
QSAR of estrogen receptor modulators: exploring selectivity requirements for ERα versus ERβ binding of tetrahydroisoquinoline derivatives using E-state and physicochemical … S Mukherjee, A Saha, K Roy Bioorganic & medicinal chemistry letters 15 (4), 957-961, 2005 | 28 | 2005 |
Substituted Aza Compounds as IRAK-4 Inhibitors VR Gummadi, S Samajdar, S Mukherjee, MG Bock US Patent App. 15/744,451, 2018 | 27 | 2018 |
Structure-guided discovery of 1, 3, 5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy R Goswami, S Mukherjee, C Ghadiyaram, G Wohlfahrt, RK Sistla, ... Bioorganic & medicinal chemistry 22 (12), 3187-3203, 2014 | 27 | 2014 |
3-Alkoxy-pyrrolo[1,2-b]pyrazolines as Selective Androgen Receptor Modulators with Ideal Physicochemical Properties for Transdermal Administration T Ullrich, S Sasmal, V Boorgu, S Pasagadi, S Cheera, S Rajagopalan, ... Journal of Medicinal Chemistry 57 (17), 7396-7411, 2014 | 26 | 2014 |
ODM-203, a selective inhibitor of FGFR and VEGFR, shows strong antitumor activity, and induces antitumor immunity TH Holmström, AM Moilanen, T Ikonen, ML Björkman, T Linnanen, ... Molecular Cancer Therapeutics 18 (1), 28-38, 2019 | 24 | 2019 |
QSAR modeling on binding affinity of diverse estrogenic flavonoids: electronic, topological and spatial functions in quantitative approximation S Mukherjee, A Mukherjee, A Saha Journal of Molecular Structure: Theochem 715 (1-3), 85-90, 2005 | 22 | 2005 |
QSAR studies with E-state index: predicting pharmacophore signals for estrogen receptor binding affinity of triphenylacrylonitriles S Mukherjee, A Mukherjee, A Saha Biological and Pharmaceutical Bulletin 28 (1), 154-157, 2005 | 21 | 2005 |
Pharmacophore mapping of selective binding affinity of estrogen modulators through classical and space modeling approaches: Exploration of bridged-cyclic compounds with … S Mukherjee, S Nagar, S Mullick, A Mukherjee, A Saha Journal of chemical information and modeling 47 (2), 475-487, 2007 | 18 | 2007 |
Pharmacophore mapping of arylbenzothiophene derivatives for MCF cell inhibition using classical and 3D space modeling approaches S Mukherjee, S Nagar, S Mullick, A Mukherjee, A Saha Journal of Molecular Graphics and Modelling 26 (5), 884-892, 2008 | 17 | 2008 |
Discovery of O-(3-carbamimidoylphenyl)-l-serine amides as matriptase inhibitors using a fragment-linking approach R Goswami, G Wohlfahrt, S Mukherjee, C Ghadiyaram, J Nagaraj, ... Bioorganic & medicinal chemistry letters 25 (3), 616-620, 2015 | 16 | 2015 |
Reproductive effects of ethnomedicinal formulation of tape-vine leaves in female rats S Mukherjee, R Banerjee, SN Upadhyay, J Hazra, KN Poddar, ... Biological and Pharmaceutical Bulletin 29 (9), 1916-1922, 2006 | 16 | 2006 |
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors R Goswami, G Wohlfahrt, O Törmäkangas, A Moilanen, ... Bioorganic & Medicinal Chemistry Letters 25 (22), 5309-5314, 2015 | 15 | 2015 |
Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders A Bhumireddy, NVMR Bandaru, BR Reddy, ST Gore, S Mukherjee, ... Bioorganic & Medicinal Chemistry Letters 55, 128448, 2022 | 13 | 2022 |
Spiro [cyclobutane-1, 3′-indolin]-2′-one Derivatives as Bromodomain Inhibitors RK Ujjinamatada, S Samajdar, C Abbineni, S Mukherjee, T Linnanen, ... US Patent 10,336,697, 2019 | 13 | 2019 |
Pyrazolo [1, 5-A][1, 3, 5] triazine and pyrazolo [1, 5-A] pyrimidine derivatives as CDK inhibitors S Samajdar, R Poddutoori, S Mukherjee, R Goswami US Patent 11,186,576, 2021 | 11 | 2021 |